ARK Genomic Revolution ETF (ARKG) Performance
ARKG total return
Distributions reinvested · as of Oct 23, 2026- YTD
- +66.2% since Dec 31, 2025
- 1 year
- +53.5% total return
- 5 years
- −8.3% a year
- 10 years
- +11.4% a year
- Since first price
- +8.3% a year since 2014
ARKG trailing returns vs SPY, QQQ, AGG
| Period | ARKG total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | −5.4% | −5.4% | −1.0% | −5.0% | +0.9% |
| 3 months | +24.1% | +24.1% | +3.2% | +1.9% | −0.4% |
| 6 months | +61.6% | +61.6% | +7.8% | +8.4% | −1.5% |
| YTD | +66.2% | +66.2% | +12.3% | +15.1% | −1.0% |
| 1 year | +53.5% | +53.5% | +14.4% | +15.9% | −1.1% |
| 3 years | +104.3%+26.9%/yr | +104.3% | +87.4%+23.3%/yr | +101.4%+26.3%/yr | +16.6%+5.2%/yr |
| 5 years | −35.2%−8.3%/yr | −35.6% | +79.3%+12.4%/yr | +94.0%+14.2%/yr | −0.8%−0.2%/yr |
| 10 years | +194.3%+11.4%/yr | +172.6% | +315.9%+15.3%/yr | +538.9%+20.4%/yr | +14.0%+1.3%/yr |
| Since inceptionOct 31, 2014 | +158.8%+8.3%/yr | +139.6% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: ARKG vs SPY
From Oct 31, 2014: ARKG grew to $25,875, SPY to $45,989.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
ARKG returns by calendar year
5 of 11 full years positive. Best 2020 (+180.4%), worst 2022 (−53.9%). 2026 is year to date.
ARKG annual returns table
| Year | ARKG | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | +66.2% | −27.5% | +12.3% | +15.1% | −1.0% |
| 2025 | +23.0% | −38.5% | +17.7% | +20.8% | +7.2% |
| 2024 | −28.2% | −31.2% | +24.9% | +25.6% | +1.3% |
| 2023 | +16.2% | −41.7% | +26.2% | +54.9% | +5.7% |
| 2022 | −53.9% | −57.2% | −18.2% | −32.6% | −13.0% |
| 2021 | −33.9% | −48.1% | +28.7% | +27.4% | −1.8% |
| 2020 | +180.4% | −35.0% | +18.3% | +48.6% | +7.5% |
| 2019 | +44.0% | −20.7% | +31.2% | +39.0% | +8.5% |
| 2018 | −0.1% | −35.1% | −4.6% | −0.1% | +0.1% |
| 2017 | +46.6% | −11.2% | +21.7% | +32.7% | +3.6% |
| 2016 | −19.3% | −26.2% | +12.0% | +7.1% | +2.4% |
| 2015 | −1.2% | −24.2% | +1.2% | +9.4% | +0.5% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
ARKG largest drawdowns
Now 56.9% below the high| Peak | Decline | Bottom | Recovered | Fall | Underwater |
|---|---|---|---|---|---|
| Jan 20, 2021 | −83.6% | Apr 8, 2025 | not yet | 4.2 years | 5.8 years so far |
| Jun 22, 2015 | −37.4% | Feb 11, 2016 | Aug 29, 2017 | 8 months | 2.2 years |
| Aug 31, 2018 | −35.1% | Dec 21, 2018 | Apr 3, 2019 | 4 months | 7 months |
| Mar 6, 2020 | −35.0% | Mar 16, 2020 | Apr 20, 2020 | 10 days | 45 days |
| Jul 30, 2019 | −20.7% | Oct 8, 2019 | Dec 17, 2019 | 2 months | 5 months |
| Mar 9, 2018 | −17.6% | Apr 6, 2018 | Jun 14, 2018 | 28 days | 3 months |
Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.
ARKG risk statistics
| Statistic | 3 years | 5 years | 10 years | Since 2014 |
|---|---|---|---|---|
| Annualized return | +24.9% | −6.1% | +11.4% | +9.4% |
| Volatility (annualized) | 42.3% | 41.6% | 38.7% | 36.8% |
| Sharpe ratio | 0.63 | -0.03 | 0.41 | 0.37 |
| Sortino ratio | 1.07 | -0.05 | 0.66 | 0.59 |
| Best month | +22.5% | +22.5% | +30.1% | +30.1% |
| Worst month | −19.0% | −26.0% | −26.0% | −26.0% |
| Best 12 months | +95.2% | +95.2% | +214.1% | +214.1% |
| Worst 12 months | −28.2% | −55.7% | −65.7% | −65.7% |
| Positive months | 53% | 43% | 49% | 50% |
| Beta vs S&P 500 | 2.06 | 1.70 | 1.64 | — |
| Correlation with S&P 500 | 0.61 | 0.64 | 0.65 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
ARKG rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 133 | −65.7% | +8.3% | +214.1% | 57% |
| 3-year (a year) | 109 | −36.6% | +5.7% | +59.2% | 63% |
| 5-year (a year) | 85 | −21.4% | +4.5% | +45.8% | 58% |
| 10-year (a year) | 25 | −0.4% | +4.8% | +12.0% | 92% |
Every holding period starting at a month-end since 2014. Returns for 3 years and longer are annualized.
ARKG performance overview
ARK Genomic Revolution ETF (ARKG) returned +53.5% over the past year and +11.4% a year over ten years, with distributions reinvested. Since its first recorded price in 2014 it has returned +8.3% a year, turning $10,000 into about $25,875. Over the same year S&P 500 (SPY) returned +14.4%.
The deepest decline was −83.6%, from Jan 20, 2021 to Apr 8, 2025; the fund has not yet regained that high. ARKG finished 5 of its 11 full calendar years with a gain; the best year was 2020 (+180.4%) and the worst 2022 (−53.9%). Volatility has been 36.8% a year.
Related: ARKG chart, ARKG holdings. See the ARKG overview for the latest quote and fund facts.
ARKG performance FAQ
What is the ARKG return over the past year?
ARKG returned +53.5% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 53.5%.
What is the average annual return of ARKG?
ARKG has returned −8.3% a year over 5 years, +11.4% a year over 10 years, +8.3% a year since October 31, 2014 (total return, distributions reinvested).
How much would $10,000 invested in ARKG be worth?
$10,000 invested in ARKG at its first recorded close on October 31, 2014 would be worth about $25,875 on October 23, 2026 with distributions reinvested.
What was the worst year for ARKG?
The worst calendar year was 2022, with a total return of −53.9%. The best was 2020 at +180.4%.
What is the biggest drawdown of ARKG?
The largest peak-to-trough decline was −83.6% between January 20, 2021 and April 8, 2025. It has not yet recovered to that high; it is 56.9% below its peak.
How volatile is ARKG?
Over the past 3 years ARKG had an annualized volatility of 42.3% and a Sharpe ratio of 0.63 (excess return over 1–3 month T-bills per unit of risk).